360 related articles for article (PubMed ID: 28095751)
41. Honokiol improved chondrogenesis and suppressed inflammation in human umbilical cord derived mesenchymal stem cells via blocking nuclear factor-κB pathway.
Wu H; Yin Z; Wang L; Li F; Qiu Y
BMC Cell Biol; 2017 Aug; 18(1):29. PubMed ID: 28851291
[TBL] [Abstract][Full Text] [Related]
42. [Activation of nuclear factor kappaB (NF-kappaB), induction of proinflammatory cytokines in vitro and evaluation of biocompatibility of the carbonate ceramic in vivo].
Zywicka B; Czarny A; Zaczyńska E; Karaś J
Polim Med; 2006; 36(3):23-35. PubMed ID: 17190290
[TBL] [Abstract][Full Text] [Related]
43. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
Wang S; Dong S; Wang P; Tao Y; Wang Y
Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
[No Abstract] [Full Text] [Related]
44. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
45. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
46. Chronic inflammation and angiogenic signaling axis impairs differentiation of dental-pulp stem cells.
Boyle M; Chun C; Strojny C; Narayanan R; Bartholomew A; Sundivakkam P; Alapati S
PLoS One; 2014; 9(11):e113419. PubMed ID: 25427002
[TBL] [Abstract][Full Text] [Related]
47. Melatonin rescued interleukin 1β-impaired chondrogenesis of human mesenchymal stem cells.
Gao B; Gao W; Wu Z; Zhou T; Qiu X; Wang X; Lian C; Peng Y; Liang A; Qiu J; Zhu Y; Xu C; Li Y; Su P; Huang D
Stem Cell Res Ther; 2018 Jun; 9(1):162. PubMed ID: 29898779
[TBL] [Abstract][Full Text] [Related]
48. Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line.
Lehmann T; Nguyen LQ; Handel ML
J Rheumatol; 2000 Dec; 27(12):2769-76. PubMed ID: 11128662
[TBL] [Abstract][Full Text] [Related]
49. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
50. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
51. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
Alagoz M; Kherad N
Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
[TBL] [Abstract][Full Text] [Related]
52. An immunoprotective privilege of corneal epithelial stem cells against Th17 inflammatory stress by producing glial cell-derived neurotrophic factor.
Bian F; Qi H; Ma P; Zhang L; Yoon KC; Pflugfelder SC; Li DQ
Stem Cells; 2010 Dec; 28(12):2172-81. PubMed ID: 20936708
[TBL] [Abstract][Full Text] [Related]
53. Role of transforming growth factor-activated kinase-1 on tumor necrosis factor-α actions in human adipose tissue-derived stromal cells.
Lee SY; Lee JH; Shin KK; Kim DS; Kim YS; Bae YC; Jung JS
Stem Cells Dev; 2015 Apr; 24(7):836-45. PubMed ID: 25350220
[TBL] [Abstract][Full Text] [Related]
54. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
55. Long-term tumor necrosis factor treatment induces NFκB activation and proliferation, but not osteoblastic differentiation of adipose tissue-derived mesenchymal stem cells in vitro.
Salamon A; Adam S; Rychly J; Peters K
Int J Biochem Cell Biol; 2014 Sep; 54():149-62. PubMed ID: 25066315
[TBL] [Abstract][Full Text] [Related]
56. CRISPR/Cas9: at the cutting edge of hepatology.
Pankowicz FP; Jarrett KE; Lagor WR; Bissig KD
Gut; 2017 Jul; 66(7):1329-1340. PubMed ID: 28487442
[TBL] [Abstract][Full Text] [Related]
57. CRISPR/Cas 9 genome editing and its applications in organoids.
Driehuis E; Clevers H
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G257-G265. PubMed ID: 28126704
[TBL] [Abstract][Full Text] [Related]
58. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
Ren J; Zhao Y
Protein Cell; 2017 Sep; 8(9):634-643. PubMed ID: 28434148
[TBL] [Abstract][Full Text] [Related]
59. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
60. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
